Hertenstein B - Search Results

1

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.

Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, Harsdorf SV, Scheid C, Holtick U, Greinix H, Keil F, Schneider B, Sandherr M, Bug G, Tischer J, Ledderose G, Hallek M, Hiddemann W, Kolb HJ. Schmid C, et al. Among authors: hertenstein b. Blood. 2006 Aug 1;108(3):1092-9. doi: 10.1182/blood-2005-10-4165. Epub 2006 Mar 21. Blood. 2006. PMID: 16551971 Free article. Clinical Trial.

2

Persistent aplasia after chemotherapy for acute myeloid leukaemia treated with stem cell transplantation from a matched unrelated donor after dose-reduced conditioning.

Hambach L, Heil G, Hertenstein B, Ganser A. Hambach L, et al. Among authors: hertenstein b. Br J Haematol. 2002 Aug;118(2):442-4. doi: 10.1046/j.1365-2141.2002.03742.x. Br J Haematol. 2002. PMID: 12139730 Free article.

3

G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases.

Franzke A, Piao W, Lauber J, Gatzlaff P, Könecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A. Franzke A, et al. Among authors: hertenstein b. Blood. 2003 Jul 15;102(2):734-9. doi: 10.1182/blood-2002-04-1200. Epub 2003 Apr 3. Blood. 2003. PMID: 12676791 Free article.

4

Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation.

Woywodt A, Scheer J, Hambach L, Buchholz S, Ganser A, Haller H, Hertenstein B, Haubitz M. Woywodt A, et al. Among authors: hertenstein b. Blood. 2004 May 1;103(9):3603-5. doi: 10.1182/blood-2003-10-3479. Epub 2004 Jan 8. Blood. 2004. PMID: 14715625 Free article.

5

Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation.

Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, Hertenstein B, Mischak H, Weissinger EM. Kaiser T, et al. Among authors: hertenstein b. Blood. 2004 Jul 15;104(2):340-9. doi: 10.1182/blood-2004-02-0518. Epub 2004 Mar 30. Blood. 2004. PMID: 15054046 Free article.

6

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O. Kiehl MG, et al. Among authors: hertenstein b. J Clin Oncol. 2004 Jul 15;22(14):2816-25. doi: 10.1200/JCO.2004.07.130. J Clin Oncol. 2004. PMID: 15254049

7

High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation.

Bug G, Atta J, Klein SA, Hertenstein B, Bergmann L, Boehrer S, Mousset S, Hoelzer D, Martin H. Bug G, et al. Among authors: hertenstein b. Ann Hematol. 2005 Oct;84(11):748-54. doi: 10.1007/s00277-005-1075-8. Epub 2005 Jul 7. Ann Hematol. 2005. PMID: 16001243 Clinical Trial.

8

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation.

Einsele H, Reusser P, Bornhäuser M, Kalhs P, Ehninger G, Hebart H, Chalandon Y, Kröger N, Hertenstein B, Rohde F. Einsele H, et al. Among authors: hertenstein b. Blood. 2006 Apr 1;107(7):3002-8. doi: 10.1182/blood-2005-09-3786. Epub 2005 Dec 13. Blood. 2006. PMID: 16352807 Free article. Clinical Trial.

9

Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Weissinger EM, Schiffer E, Hertenstein B, Ferrara JL, Holler E, Stadler M, Kolb HJ, Zander A, Zürbig P, Kellmann M, Ganser A. Weissinger EM, et al. Among authors: hertenstein b. Blood. 2007 Jun 15;109(12):5511-9. doi: 10.1182/blood-2007-01-069757. Epub 2007 Mar 5. Blood. 2007. PMID: 17339419 Free article.

10

Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.

Hildebrandt GC, Granell M, Urbano-Ispizua A, Wolff D, Hertenstein B, Greinix HT, Brenmoehl J, Schulz C, Dickinson AM, Hahn J, Rogler G, Andreesen R, Holler E. Hildebrandt GC, et al. Among authors: hertenstein b. Biol Blood Marrow Transplant. 2008 Jan;14(1):67-74. doi: 10.1016/j.bbmt.2007.09.009. Biol Blood Marrow Transplant. 2008. PMID: 18158963 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters